Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 11, 2020 00:35:50
Episode Cover

2020 AHA Updates: Post-Arrest Care

The period following ROSC from cardiac arrest is a time when lives can be saved…or lost.  A systematic and comprehensive approach to post-arrest care...

Listen

Episode 0

November 17, 2017 00:27:56
Episode Cover

Mechanical Circulatory Support Devices

What do you do for the patient in cardiogenic shock who is not responding to vasopressors and inotropes?  Should you place a mechanical circulatory...

Listen

Episode 0

March 17, 2024 00:22:04
Episode Cover

Steroids in Sepsis, ARDS, and CAP - A Focused Clinical Update

Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties.  In recent years, several...

Listen